HOME >> BIOLOGY >> NEWS
Tumor cells made more sensitive to radiation by blocking a key cellular molecule

In recent years, cancer researchers have sought ways to make tumors more receptive to treatment. In a series of novel experiments, scientists at the University of North Carolina at Chapel Hill have succeeded in making tumor cells more sensitive to destruction by radiation therapy.

This was accomplished in colorectal tumor cells by two experimental interventions aimed at blocking activation of a cellular protein, NF-kappaB.

The findings will be detailed in Boston, Wednesday, October 25, at the annual meeting of the American Society for Therapeutic Radiation and Oncology.

Earlier research has shown that activation of the molecule in some tumor types inhibits the cellular self-destruction process called apoptosis. Moreover, ionizing radiation, which is used against malignancies, and some anti-cancer drugs, also may induce NF-kappaB activation.

"This can reduce the cell-killing effects of chemotherapy or radiation," said Joel E. Tepper, MD, head of radiation oncology at UNC-CH School of Medicine and a member of UNC Lineberger Comprehensive Cancer Center. "But it's also known you can inhibit the inhibition of apoptosis. And if you can do that, you may be able to do a more effective job of killing tumor cells with standard anticancer therapies."

The UNC experiments were aimed at determining if the effects of radiation would be enhanced against tumor cells in which NF-kappaB activation was inhibited. Suzanne M. Russo, MD, a former radiation oncology resident at UNC, and now a radiation oncologist at Wake Forest University led the study. Collaborators included Tepper and other Lineberger Center members Albert S. Baldwin, PhD, and James C. Cusack, MD.

The team investigated colorectal tumor cells in lab dishes and in tumors grown on mice. In carefully controlled experiments, they studied two methods of inhibiting NF-kappaB activation. One is the experimental drug PS-341, a proteosome inhibitor chemical that prevents the cell from degrading or
'"/>

Contact: Leslie H. Lang
LLANG@MED.UNC.EDU
919-843-9687
University of North Carolina School of Medicine
24-Oct-2000


Page: 1 2

Related biology news :

1. Tumor cell-specific therapy shows preclinical promise
2. Discovery Of 13 Genes Expressed In Brain Tumors May Lead To More Effective Diagnosis Or Prevention
3. Dietary Lutein Inhibits Mammary Tumor Growth And Normalizes Immune Balance In Tumor-Bearing Mice
4. Tumor Oxygen Level And Blood Flow Fluctuate, Duke Scientists Discover
5. Vion Demonstrates Readiness Of First Tumor-Targeting Salmonella For Human Testing Against Solid Tumors
6. Compounds From Fruits, Vegetables And Grains Slow The Growth Of Human Tumor Cells
7. New Cell Isolation Method Will Aid In Studying Tumor Development
8. Wistar Institute To Host 3rd International Conference On Molecular And Clinical Genetics Of Childhood Renal Tumors And The Mitchell Ross Symposium
9. Scientists Study Proteins Role In Tumor Development In Fish
10. Fly Tumor Points Way To New Understanding Of Cancer Development
11. Vions TAPET Organisms Demonstrate Reduced Virulence, Increased Safety While Retaining Ability To Specifically Target Tumors

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
Breaking Biology News(10 mins):
(Date:4/27/2017)... ... 2017 , ... Arrowhead Publishers is pleased to announce the ... San Diego, CA on September 27-28, 2017. Leaders from the pharmaceutical, biotech, device ... the treatment of various types of pain. There are also extended networking opportunities, ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... mass flow controllers based on capillary thermal mass flow technology provide exponentially more ... control applications. Over 80% of all industrial processes—such as those involving chemical ...
(Date:4/27/2017)... Washington, USA (PRWEB) , ... April 27, 2017 ... ... for optics and photonics , joined other scientists, researchers, engineers, and industry professionals ... measures to strengthen America's ability to compete in the world photonics industry. , ...
(Date:4/27/2017)... 2017  Pendant Biosciences, Inc. (formerly Nanoferix, Inc.), a ... drug delivery technologies, today announced that it has been ... Toronto . Shawn Glinter ... noted, "We are excited to become part of the ... are honored to be the first Tennessee ...
Breaking Biology Technology:
Cached News: